Modalis Therapeutics
4883.TTSE GROWTHPharmaceutical
Major holders (5%+) · 3
| Holder | Stake |
|---|---|
| Evo Fund | 7.61% |
| Life Science Innovation Management Inc. | 6.28% |
| LSIM Inc. | 5.02% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 5
| SBI SECURITIES Co., Ltd. | 3.77% |
| Osamu Nureki | 3.58% |
| SBI Investment Co., Ltd. | 0.69% |
| Haruhiko Morita | 0.38% |
| Evolution Capital Management LLC | 0.00% |
Ownership history · 177
| Holder | Ratio | Change |
|---|---|---|
| Haruhiko Morita2025-08-12 | 0.47% | -0.68pp |
| Life Science Innovation Management Inc.2025-08-12 | 6.28% | -9.02pp |
| Haruhiko Morita2025-06-18 · amended | 1.15% | +0.68pp |
| Life Science Innovation Management Inc.2025-06-18 · amended | 15.30% | +9.02pp |
| Haruhiko Morita2025-05-30 · amended | 0.47% | -0.02pp |
| Life Science Innovation Management Inc.2025-05-30 · amended | 6.28% | -0.17pp |
| Evolution Capital Management LLC2025-05-23 · amended | 0.00% | no change |
| Evo Fund2025-05-23 · amended | 4.42% | -1.45pp |
| Haruhiko Morita2025-05-02 · amended | 0.49% | no change |
| Life Science Innovation Management Inc.2025-05-02 · amended | 6.45% | +2.67pp |
| Haruhiko Morita2025-05-02 · amended | 0.49% | -0.43pp |
| Life Science Innovation Management Inc.2025-05-02 · amended | 3.78% | -8.47pp |
| Evolution Capital Management LLC2025-04-28 · amended | 0.00% | no change |
| Evo Fund2025-04-28 · amended | 5.87% | -1.14pp |
| Evolution Capital Management LLC2025-04-17 · amended | 0.00% | no change |
| Evo Fund2025-04-17 · amended | 7.01% | -1.17pp |
| Evolution Capital Management LLC2025-02-14 · amended | 0.00% | no change |
| Evo Fund2025-02-14 · amended | 8.18% | -1.45pp |
| Evolution Capital Management LLC2025-01-31 · amended | 0.00% | no change |
| Evo Fund2025-01-31 · amended | 9.63% | -1.41pp |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.